We established that BAPT-AM (Ca2+ chelator) reverses hyperglycemia induced-mitochondrial dysfunction and apoptosis via the mPTP-mediated Cyt c/caspase-3 pathway, suggesting that mitochondrial Ca2+ overload accelerates the DR process via mitochondrial dysfunction. This evidence concerns the gene CASP3 and Hyperglycemia.